UniSuper Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
UniSuper Management's RVMD Position: Q3 2026 in Review
UniSuper Management increased its Revolution Medicines (RVMD) stake by 35% in Q3 2026, buying an estimated $317K and bringing the position to 6,189 shares worth $1.27M. The position accounts for 0.01% of the portfolio, ranked #493.
UniSuper Management first reported a position in RVMD in Q1 2026 and has held it in 3 quarters since. 758 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- UniSuper Management held 6,189 shares of Revolution Medicines worth $1.27M as of Q3 2026.
- UniSuper Management bought 1,600 Revolution Medicines shares in Q3 2026, an estimated $317K.
- Revolution Medicines made up 0.01% of UniSuper Management's portfolio in Q3 2026, its #493 holding.
- UniSuper Management first reported a position in Revolution Medicines in Q1 2026 and has held it in 3 quarters since.
- 758 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on UniSuper Management's 13F filing for Q3 2026, filed 26 Oct 2026.